🇺🇸 FDA

Company profile · Sponsor

Centessa

Centessa Pharmaceuticals plc

CNTA · NYSE pharma ALTRINCHAM, CHESHIRE, X0, USA
Pipeline
15
Drugs
0
Patents
7

Quick answer

Centessa (CNTA) is a pharma company. headquartered in ALTRINCHAM, CHESHIRE, X0, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 7 patents to this profile..

Company facts

Ticker CNTA
Exchange NYSE
Company type pharma
Headquarters ALTRINCHAM, CHESHIRE, X0, USA
SEC CIK 0001847903

Pipeline (15)

Search pipeline →

  1. Lixivaptan

    Centessa

    Polycystic Kidney Disease, Adult

    phase 3 small molecule terminated

    2 trials

  2. Lixivaptan

    Centessa

    Autosomal Dominant Polycystic Kidney

    phase 3 small molecule terminated

    1 trial

  3. SerpinPC

    Centessa

    Hemophilia a

    phase 3 small molecule completed

    3 trials

  4. cleminorexton

    Centessa

    Narcolepsy Type 1

    phase 3 small molecule active

    1 trial

  5. A Phase 1/2a, First in Human, Open-Label, Multicenter, Dose Escalation Study with Expansion Cohorts to Evaluate the Safety, Tolerability, and Preliminary Activity of LB101 in Subjects with Advanced Solid Tumors

    Centessa

    Advanced solid tumors

    phase 2 other active

    1 trial

  6. Imgatuzumab

    Centessa

    Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  7. LB101

    Centessa

    Advanced Solid Tumor

    phase 2 small molecule terminated

    1 trial

  8. ORX750

    Centessa

    Narcolepsy Type 1

    phase 2 small molecule active

    2 trials

  9. ORX750, ORX750, ORX750, ORX750

    Centessa

    Narcolepsy and Idiopathic Hypersomnia

    phase 2 small molecule active

    1 trial

  10. ORX750, ORX750, ORX750, Orx750 matching placebo, ORX750

    Centessa

    Narcolepsy and Idiopathic Hypersomnia

    phase 2 small molecule active

    1 trial

  11. SerpinPC

    Centessa

    Hemophilia B with Inhibitor

    phase 2 small molecule terminated

    1 trial

  12. CBS001

    Centessa

    Chronic Inflammatory Disease

    phase 1 small molecule terminated

    1 trial

  13. ORX142 Tablets

    Centessa

    Excessive Daytime Sleepiness

    phase 1 small molecule active

    1 trial

  14. ORX489 Tablets

    Centessa

    Healthy Adult Male and Female Volunteers

    phase 1 small molecule active

    1 trial

  15. ZF874

    Centessa

    Alpha1 Anti-Trypsin Deficiency

    phase 1 small molecule terminated

    1 trial

Patents (7)

Search patents →

  1. US 12421310

    CD47 binding agents

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12415861

    Anti C-MET antibodies

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12365672

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12291507

    Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12286402

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12227580

    Antigen binding molecules that bind LIGHT

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12221422

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Centessa?

Centessa (CNTA) is a pharma company. headquartered in ALTRINCHAM, CHESHIRE, X0, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 7 patents to this profile..

What pipeline programs does Centessa sponsor?

We track 15 ClinicalTrials.gov-linked programs for Centessa, including Lixivaptan and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Centessa company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.